Venous malformation: Update on aetiopathogenesis, diagnosis and management

Phlebology

Volumn 25, Issue 5, 2010, Pages 224-235

  Dompmartin, A ^a   Vikkula, M ^b   Boon, L M ^b,c  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b DE DUVE INSTITUTE   (Belgium)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

D dimer; Ethylcellulose ethanol; Klippel Trenaunay syndrome; Maffuci syndrome; Sclerotherapy

Indexed keywords

BIOLOGICAL MARKER; D DIMER; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANGIOOSTEOHYPERTROPHY SYNDROME; CLINICAL FEATURE; COMPRESSION GARMENT; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG RESPONSE; FAMILY HISTORY; GENETIC ANALYSIS; HEREDITY; HISTOPATHOLOGY; HUMAN; NONHUMAN; OSTEOCHONDROMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCLEROTHERAPY; VEIN MALFORMATION;

DISEASE MANAGEMENT; HEMANGIOMA; HUMANS; NEVUS; VASCULAR MALFORMATIONS;

EID: 77958017956     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1258/phleb.2009.009041     Document Type: Review

References (79)

1. Mulliken JB, Glowacki J. Haemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-22
2. Mulliken JB, Young AE. Vascular Birthmarks: Hemangiomas and Malformations. Philadelphia: WB Saunders, 1988
3. Enjolras O, Mulliken JB. Vascular cutaneous anomalies in children: malformations and haemangiomas. Pediatr Surg Int 1996;11:290-5
4. Lee BB, Laredo J, Lee TS, Huh S, Neville R. Terminology and classification of congenital vascular malformations. Phlebology 2007;22:249-52
5. Belov S. Classification of congenital vascular defects. Int Angiol 1990;9:141-6
6. Boon LM, Mulliken JB, Vikkula M, et al. Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet 1994;3:1583-7
7. Eerola I, Boon LM, Mulliken JB, et al. Capillary malformation- arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 2003;73:1240-9
8. Boon LM, Fishman SJ, Lund DP, Mulliken JB. Congenital fibrosarcoma masquerading as congenital hemangioma: report of two cases. J Pediatr Surg 1995;30:1378-81
9. Dompmartin A, Boon LM, Labbe D. Infantile hemangiomas: differential diagnosis and associated anomalies. Ann Chir Plast Esthet 2006;51:300-9
10. Boon LM, Vikkula M. Vascular anomalies. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell D eds. Fitzpatrick's Dermatology in General Medicine. 7th edn., Vol. 2. McGraw-Hill Professional Publishing, 2008:1651-66
11. Dompmartin A, Bailleux F, Thibon P, et al. Elevated D-dimer level is diagnostic for venous malformations. Arch Dermatol 2009;145:1239-44
12. Brouillard P, Vikkula M. Genetic causes of vascular malformations. Hum Mol Genet 2007;16 Spec No. 2:R140-9
13. Limaye N, Boon LM, Vikkula M. From germline towards somatic mutations in the pathophysiology of vascular anomalies. Hum Mol Genet 2009;18(R1):R65-74
14. Brouillard P, Boon LM, Mulliken JB, et al. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ('glomangiomas'). Am J Hum Genet 2002;70:866-74
15. Casanova D, Boon LM, Vikkula M. Venous malformations: clinical characteristics and differential diagnosis. Ann Chir Plast Esthet 2006;51:373-87
16. Vikkula M, Boon LM, Carraway KL III et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 1996;87:1181-90
17. Vikkula M, Boon LM, Mulliken JB. Molecular genetics of vascular malformations. Matrix Biol 2001;20:327-35
18. Boon LM, Mulliken JB, Enjolras O, Vikkula M. Glomuvenous malformation (glomangioma) and venous malformation: distinct clinicopathologic and genetic entities. Arch Dermatol 2004;140:971-6
19. Mallory SB, Enjolras O, Boon LM, et al. Congenital plaque-type glomuvenous malformations presenting in childhood. Arch Dermatol 2006;142:892-6
20. Song M, Ko HC, Kwon KS, Kim MB. Surgical treatment of subungual glomus tumor: a unique and simple method. Dermatol Surg 2009;35:786-91
21. Enjolras O, Ciabrini D, Mazoyer E, Laurian C, Herbreteau D. Extensive pure venous malformations in the upper or lower limb: a review of 27 cases. J Am Acad Dermatol 1997;36(2 Pt 1):219-25
22. Mazoyer E, Enjolras O, Bisdorff A, Perdu J, Wassef M, Drouet L. Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients. Arch Dermatol 2008;144:861-7
23. Hermans C, Dessomme B, Lambert C, Deneys V. Venous malformations and coagulopathy. Ann Chir Plast Esthet 2006;51:388-93
24. Boon LM, Brouillard P, Irrthum A, et al. A gene for inherited cutaneous venous anomalies ('glomangiomas') localizes to chromosome 1p21-22. Am J Hum Genet 1999;65:125-33
25. Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg 2000;37:517-84
26. Tennant LB, Mulliken JB, Perez-Atayde AR, Kozakewich HP. Verrucous hemangioma revisited. Pediatr Dermatol 2006;23:208-15
27. Bean W. Vascular spiders and related lesions of the skin. In: Thomas CC, ed. Springfield, III. Oxford: Blackwell Scientific Publications, 1959
28. Fishman SJ, Smithers CJ, Folkman J, et al. Blue rubber bleb naevus syndrome: surgical eradication of gastrointestinal bleeding. Ann Surg 2005;241:523-8
29. Berry SA, Peterson C, Mize W, et al. Klippel-Trenaunay syndrome. Am J Med Genet 1998;79:319-26
30. Cohen MM Jr. Klippel-Trenaunay syndrome. Am J Med Genet 2000;93:171-5
31. Oduber CE, van der Horst CM, Hennekam RC. Klippel- Trenaunay syndrome: diagnostic criteria and hypothesis on etiology. Ann Plast Surg 2008;60:217-23
32. Huiras EE, Barnes CJ, Eichenfield LF, Pelech AN, Drolet BA. Pulmonary thromboembolism associated with Klippel-Trenaunay syndrome. Pediatrics 2005;116:e596-600
33. Wassef M, Vanwijck R, Clapuyt P, Boon L, Magalon G. Vascular tumours and malformations, classification, pathology and imaging. Ann Chir Plast Esthet 2006;51:263-81
34. Maffucci A. Di un caso encondroma ed angioma multiplo. Contribuzione alla genesi embrionale dei tumori. In Movimento medico-chirurgico. Vol. 3. Napoli, 1881:399-412, 565-75
35. Enjolras O, Wassef M, Merland JJ. Maffucci syndrome: a false venous malformation? A case with hemangioendothelioma with fusiform cells. Ann Dermatol Venereol 1998;125:512-15
36. Lewis RJ, Ketcham AS. Maffucci's syndrome: functional and neoplastic significance. Case report and review of the literature. J Bone Joint Surg Am 1973;55:1465-79
37. Schwartz HS, Zimmerman NB, Simon MA, Wroble RR, Millar EA, Bonfiglio M. The malignant potential of enchondromatosis. J Bone Joint Surg Am 1987;69:269-74
38. Kaplan RP, Wang JT, Amron DM, Kaplan L. Maffucci's syndrome: two case reports with a literature review. J Am Acad Dermatol 1993;29(5 Pt 2):894-9
39. Zembowicz A, Mihm MC. Dermal dendritic melanocytic proliferations: an update. Histopathology 2004;45:433-51
40. Trop I, Dubois J, Guibaud L, et al. Soft-tissue venous malformations in pediatric and young adult patients: diagnosis with Doppler US. Radiology 1999;212:841-5
41. Hein KD, Mulliken JB, Kozakewich HP, Upton J, Burrows PE. Venous malformations of skeletal muscle. Plast Reconstr Surg 2002;110:1625-35
42. Dubois J, Soulez G, Oliva VL, Berthiaume MJ, Lapierre C, Therasse E. Soft-tissue venous malformations in adult patients: imaging and therapeutic issues. Radiographics 2001;21:1519-31
43. Konez O, Burrows PE. Magnetic resonance of vascular anomalies. Magn Reson Imaging Clin N Am 2002;10:363-88, vii
44. Goyal M, Causer PA, Armstrong D. Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification. Radiology 2002;223:639-44
45. Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 1999;104:1-11; discussion 12-15
46. Lee BB, Laredo J, Kim YW, Neville R. Congenital vascular malformations: general treatment principles. Phlebology 2007;22:258-63
47. Revencu N, Boon LM, Mulliken JB, et al. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat 2008;29:959-65
48. Eerola I, Plate KH, Spiegel R, Boon LM, Mulliken JB, Vikkula M. KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation. Hum Mol Genet 2000;9:1351-5
49. Revencu N, Vikkula M. Cerebral cavernous malformation: new molecular and clinical insights. J Med Genet 2006;43:716-21
50. Limaye N, Wouters V, Uebelhoer M, et al. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet 2009;41:118-24
51. Toll A, Parera E, Gimenez-Arnau AM, et al. Cutaneous venous malformations in familial cerebral cavernomatosis caused by KRIT1 gene mutations. Dermatology (Basel, Switzerland) 2009;218:307-13
52. Sirvente J, Enjolras O, Wassef M, Tournier-Lasserve E, Labauge P. Frequency and phenotypes of cutaneous vascular malformations in a consecutive series of 417 patients with familial cerebral cavernous malformations. J Eur Acad Dermatol Venereol 2009;23:1066-72
53. Couvineau A, Wouters V, Bertrand G, et al. PTHR1 mutations associated with Ollier disease result in receptor loss of function. Hum Mol Genet 2008;17:2766-75
54. Tian XL, Kadaba R, You SA, et al. Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature 2004;427:640-5
55. Gutierrez S, Magano L, Delicado A, et al. The G397A (E133K) change in the AGGF1 (VG5Q) gene is a single nucleotide polymorphism in the Spanish population. Am J Med Genet A 2006;140:2832-3
56. Barker KT, Foulkes WD, Schwartz CE, et al. Is the E133K allele of VG5Q associated with Klippel-Trenaunay and other overgrowth syndromes? J Med Genet 2006;43:613-14
57. Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol 1997;13:375-423
58. Dompmartin A, Acher A, Thibon P, et al. Association of localized intravascular coagulopathy with venous malformations. Arch Dermatol 2008;144:873-7
59. Kluft C, Meijer P, LaGuardia KD, Fisher AC. Comparison of a transdermal contraceptive patch versus oral contraceptives on hemostasis variables. Contraception 2008;77:77-83
60. Johnson JV, Lowell J, Badger GJ, Rosing J, Tchaikovski S, Cushman M. Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial. Obstet Gynecol 2008;111(2 Pt 1):278-84
61. Dompmartin A, Thibon P, Vikkula M, Boon LM. Oral contraceptive and D-dimer level. Arch Dermatol 2009;145:210-11
62. Falanga V, Kruskal J, Franks JJ. Fibrin- and fibrinogen-related antigens in patients with venous disease and venous ulceration. Arch Dermatol 1991;127:75-8
63. Cuderman TV, Bozic M, Peternel P, Stegnar M. Hemostasis activation in thrombophilic subjects with or without a history of venous thrombosis. Clin Appl Thromb Hemost 2008;14:55-62
64. Oduber CE, Gerdes VE, van der Horst CM, Bresser P. Vascular malformations as underlying cause of chronic thromboembolism and pulmonary hypertension. J Plast Reconstr Aesthet Surg 2009;62:684-9; discussion 689
65. Boon LM, Vanwijck R. Medical and surgical treatment of venous malformations. Ann Chir Plast Esthet 2006;51:403-11
66. Rosenblatt M. Endovascular management of venous malformations. Phlebology 2007;22:264-75
67. Yakes WF, Haas DK, Parker SH, et al. Symptomatic vascular malformations: ethanol embolotherapy. Radiology 1989;170(3 Pt 2):1059-66
68. Rivas S, Lopez-Gutierrez JC, Diaz M, Andres AM, Ros Z. [Venous malformations. Diagnosis and treatment during the childhood]. Cir Pediatr 2006;19:77-80
69. Schumacher M, Ernemann U, Berlis A, Weber J. Treatment of venous malformations - comparison to lymphatic malformations. Lymphology 2008;41:139-46
70. Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol 2004;15:431-45
71. Forlee MV, Grouden M, Moore DJ, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 2006;43:162-4
72. Li L, Feng J, Zeng XQ, Li YH. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience. J Vasc Surg 2009;49:961-7
73. Cabrera J, Cabrera J Jr, Garcia-Olmedo MA, Redondo P. Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol 2003;139:1409-16
74. Dompmartin A, Gaillard C, Theron J, et al. Radioopaque ethylcellulose ethanol is a safe and efficient sclerosing agent for slow-flow vascular malformations. Submitted to JVIR
75. Suh JS, Shin KH, Na JB, Won JY, Hahn SB. Venous malformations: sclerotherapy with a mixture of ethanol and lipiodol. Cardiovasc Intervent Radiol 1997;20:268-73
76. Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T. Prospective randomized efficacy of ultrasound- guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg 2008;47:578-84
77. Bergan J, Cheng V. Foam sclerotherapy of venous malformations. Phlebology 2007;22:299-302
78. Sannier K, Dompmartin A, Théron J, et al. A new sclerosing agent in the treatment of venous malformations. Study on 23 cases. Interven Radiol 2004;10:113-27
79. Dompmartin A, Labbe D, Theron J, Benateau H, Barrellier MT. The use of an alcohol gel of ethyl cellulose in the treatment of venous malformations. Rev Stomatol Chir Maxillofac 2000;101:30-2